CME Medical Grand Rounds ~ T-cell Lymphomas in 2015: Science and Clinical Practice

EVENT DETAILS AND REGISTRATION

Date:November 17, 2015

Time: 12:00 PM - 01:00 PM (PT)

Location:Conference Room B

Event Is:

  • Distinguish between the various T-cell lymphoma subtypes and recognize histopathologic, clinical and the molecular, features that aid in accurate diagnosis and guide treatment decisions
  • Describe current treatment options for peripheral (PTCL) and cutaneous (CTCL) T-cell lymphoma subtypes and how recent clinical trials data with existing and emerging agents can be integrated into evidence-based clinical management strategies
  • Evaluate the efficacy and safety data from studies of current and emerging treatment options to improve outcomes in patients with  PTCL and CTCL
  • Summarize new data and possible treatment algorithms that can be used in community practice to achieve the best outcomes for patients PTCL and CTCL
  • Understand current evidence regarding the role of bone marrow transplantation in PTCL and CTCL

Presenters:Andrei R. Shustov, MD

ADDITIONAL DETAILS:

Objectives:

  • Distinguish between the various T-cell lymphoma subtypes and recognize histopathologic, clinical and the molecular, features that aid in accurate diagnosis and guide treatment decisions
  • Describe current treatment options for peripheral (PTCL) and cutaneous (CTCL) T-cell lymphoma subtypes and how recent clinical trials data with existing and emerging agents can be integrated into evidence-based clinical management strategies
  • Evaluate the efficacy and safety data from studies of current and emerging treatment options to improve outcomes in patients with  PTCL and CTCL
  • Summarize new data and possible treatment algorithms that can be used in community practice to achieve the best outcomes for patients PTCL and CTCL
  • Understand current evidence regarding the role of bone marrow transplantation in PTCL and CTCL

Who should attend:

Medical oncologists, hematologists, pathologists, hematopathologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers and other health care professionals interested in the diagnosis and treatment of patients with peripheral and cutaneous T-cell lymphoma

Sponsor(s):Educational Grant from Celgene Corporation and Spectrum Pharmaceuticals

CME credits:1.0 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM

R.S.V.P.: First Come First Serve

Contact:

CME Department